Inventor · disambiguated record
Craig Stivala
Also filed as: STIVALA CRAIG
16 granted patents·7 pending applications·22 citations·filing 2016–2025
88Inventor score
Top patents by PatentIndex Score
23 records- 0195US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0293US10988459B2Bicyclic lactams and methods of use thereofGENENTECH INC·Filed 2016·Granted Apr 27, 2021·7 cites·31 claims
- 0390US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0489US11098058B2Bicyclic ketone compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Aug 24, 2021·3 cites·27 claims
- 0583US11072617B2Bicyclic sulfones and sulfoxides and methods of use thereofGENENTECH INC·Filed 2018·Granted Jul 27, 2021·2 cites·35 claims
- 0681US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 0775US2025115618A1Sulfonimidamide compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2024·Application pending·0 cites
- 0874US2024300974A1Bicyclic ketone compounds and methods of use thereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 0968US2025282788A1Bicyclic ketone compounds and methods of use thereofGENENTECH INC·Filed 2025·Application pending·0 cites
- 1068US2025122171A1Substituted Amine Compounds, Compositions and Methods of UseDEEP APPLE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1165US12344612B2Bicyclic ketone compounds and methods of use thereofGENENTECH INC·Filed 2021·Granted Jul 1, 2025·0 cites·12 claims
- 1265US12281101B2Bicyclic lactams and methods of use thereofGENENTECH INC·Filed 2021·Granted Apr 22, 2025·0 cites·15 claims
- 1365US11834461B2Bicyclic ketone compounds and methods of use thereofGENENTECH INC·Filed 2021·Granted Dec 5, 2023·0 cites·11 claims
- 1464US12338241B2Bicyclic sulfones and sulfoxides and methods of use thereofGENENTECH INC·Filed 2021·Granted Jun 24, 2025·0 cites·21 claims
- 1561US12234245B2Sulfonimidamide compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2021·Granted Feb 25, 2025·0 cites·19 claims
- 1660US2024336625A1Sulfonimidamde compounds and uses thereofGENENTECH INC·Filed 2022·Application pending·0 cites
- 1760US2023159555A1Sulfonimidamide compounds as nlrp3 modulatorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1854US12208088B2Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereofGENENTECH INC·Filed 2021·Granted Jan 28, 2025·0 cites·29 claims
- 1954US11560391B2Sulfonylurea compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2021·Granted Jan 24, 2023·0 cites·21 claims
- 2054US2018282282A1Isoquinolines as inhibitors of hpk1GENENTECH INC·Filed 2018·Application pending·0 cites
- 2153US12378249B2Isoquinoline compounds and uses thereofGENENTECH INC·Filed 2021·Granted Aug 5, 2025·0 cites·25 claims
- 2253US12297210B2Naphthyridine compounds and uses thereofGENENTECH INC·Filed 2021·Granted May 13, 2025·0 cites·15 claims
- 2343US11673892B2Bicyclic compounds for use as RIP1 kinase inhibitorsGENENTECH INC·Filed 2020·Granted Jun 13, 2023·0 cites·29 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →